Opioid-modulating properties of the neuropeptide FF system

Biofactors. 2010 Nov-Dec;36(6):423-9. doi: 10.1002/biof.116. Epub 2010 Aug 27.

Abstract

Opioid receptors are involved in the control of pain perception in the central nervous system together with endogenous neuropeptides, termed opioid-modulating peptides, participating in a homeostatic system. Neuropeptide FF (NPFF) and related peptides possess anti-opioid properties, the cellular mechanisms of which are still unclear. The purpose of this review is to detail the phenomenon of cross-talk taking place between opioid and NPFF systems at the in vivo pharmacological level and to propose cellular and molecular models of functioning. A better knowledge of the mechanisms underlying opioid-modulating properties of NPFF has potential therapeutic interest for the control of opioid functions, notably for alleviating pain and/or for the treatment of opioid abuse.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Analgesics, Opioid / pharmacology*
  • Animals
  • Cattle
  • Humans
  • Mice
  • Models, Molecular
  • Molecular Sequence Data
  • Morphine / pharmacology*
  • Narcotic Antagonists*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Oligopeptides* / pharmacology
  • Opioid Peptides / antagonists & inhibitors*
  • Opioid Peptides / metabolism
  • Rats
  • Receptor Cross-Talk / drug effects*
  • Receptors, Opioid / metabolism*

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Oligopeptides
  • Opioid Peptides
  • Receptors, Opioid
  • Morphine
  • phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide